Salesforce (CRM) shares have declined more than 30% year-to-date. The stock is currently trading near 52-week lows following a multi-session losing streak. Barron’s removed its buy recommendation on June 11, citing a failure to re-accelerate sales growth.
First-quarter earnings results surpassed analyst estimates in late May. However, forward-looking guidance for the second quarter and fiscal year 2027 fell short of expectations. The company projects full-year organic revenue growth of approximately 8%.
The Agentforce AI platform reached an annual recurring revenue of $1.2 billion. Despite this milestone, negative sentiment persists following a minor round of layoffs and a new acquisition in early June.